Allison O'neill, Md

This study tests the drug pembrolizumab (Keytruda) in children and young adults up to age 30 whose liver cancer has come back or not responded to treatment. The goal is to see if the drug can shrink tumors or slow the disease. About 18 participants will receive the immunotherapy,…